Form 8-K - Current report:
SEC Accession No. 0001493152-24-017937
Filing Date
2024-05-06
Accepted
2024-05-06 17:00:41
Documents
14
Period of Report
2024-05-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43760
2 ex99-1.htm EX-99.1 14608
  Complete submission text file 0001493152-24-017937.txt   231714

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE mrzm-20240506.xsd EX-101.SCH 3015
4 XBRL LABEL FILE mrzm-20240506_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE mrzm-20240506_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3347
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

EIN.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 24918434
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)